Todd Asset Management LLC Increases Stock Position in GE HealthCare Technologies Inc. $GEHC

Todd Asset Management LLC increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 478,961 shares of the company’s stock after purchasing an additional 85,163 shares during the quarter. Todd Asset Management LLC owned 0.11% of GE HealthCare Technologies worth $35,970,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State of New Jersey Common Pension Fund D boosted its position in GE HealthCare Technologies by 3.6% in the third quarter. State of New Jersey Common Pension Fund D now owns 157,458 shares of the company’s stock worth $11,825,000 after purchasing an additional 5,522 shares during the last quarter. HighTower Advisors LLC boosted its holdings in GE HealthCare Technologies by 184.7% in the 3rd quarter. HighTower Advisors LLC now owns 392,674 shares of the company’s stock worth $29,490,000 after buying an additional 254,756 shares during the period. Aberdeen Group plc increased its stake in GE HealthCare Technologies by 55.6% in the 3rd quarter. Aberdeen Group plc now owns 174,328 shares of the company’s stock worth $13,092,000 after buying an additional 62,263 shares in the last quarter. GF Fund Management CO. LTD. lifted its position in shares of GE HealthCare Technologies by 1.2% in the third quarter. GF Fund Management CO. LTD. now owns 103,652 shares of the company’s stock valued at $7,784,000 after acquiring an additional 1,207 shares in the last quarter. Finally, CENTRAL TRUST Co boosted its stake in shares of GE HealthCare Technologies by 58.7% in the third quarter. CENTRAL TRUST Co now owns 18,396 shares of the company’s stock worth $1,382,000 after acquiring an additional 6,805 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $80.34 on Monday. The business’s 50 day moving average price is $82.44 and its 200-day moving average price is $77.66. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $93.26. The company has a market cap of $36.61 billion, a P/E ratio of 17.62, a P/E/G ratio of 1.77 and a beta of 1.09. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on GEHC shares. Bank of America lifted their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Barclays boosted their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price target for the company from $73.00 to $77.00 in a report on Thursday, January 15th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.